Spiro Rombotis - President and CEO, Director at Cyclacel Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
CYCC, CYCCP on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Spiro Rombotis - trading volume in the past year for Cyclacel Pharmaceuticals, Inc.

Holdings reported by Spiro Rombotis for Cyclacel Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 68.7K $228K $3.32 Dec 21, 2023 Direct
Stock Option (right to buy) 110K Jun 30, 2023 Direct Common Stock
Warrants (right to buy) 6.07K Dec 21, 2023 Direct Common Stock

Transactions reported by Spiro Rombotis for Cyclacel Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.